By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > What Clinicians Should Know About B12 Absorption: Three Essential Principles

What Clinicians Should Know About B12 Absorption: Three Essential Principles

GMJ
Last updated: 27/06/2026 13:07
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Chart showing vitamin B12 absorption rates at different dosage levels
Research reveals how vitamin B12 supplements overcome absorption limitations through a backup pathway. While efficiency drops dramatically at high doses, total absorption continues rising significantly. — Photo: Anna Shvets / Pexels
SHARE
1 min read|134 words

Understanding vitamin B12 absorption requires knowledge of two distinct physiological mechanisms that operate under different constraints. The primary pathway, mediated by intrinsic factor, is highly efficient but severely limited—it saturates at approximately 1.5 micrograms regardless of dose size. This ceiling explains why patients cannot simply increase intrinsic factor-dependent absorption through larger oral doses. The secondary mechanism, passive diffusion, operates without such constraints, absorbing 1-2% of any B12 amount consumed throughout the entire digestive tract. This means a 1,000 microgram supplement delivers roughly 10 micrograms via diffusion alone—sufficient to meet daily requirements even when the primary pathway is compromised. Clinicians should recognize that high-dose supplements function not through improved efficiency, but through activation of compensatory absorption mechanisms. This distinction informs patient selection, dosing strategies, and expectations for therapeutic outcomes. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Why High-Dose Vitamin B12 Supplements Work Despite Poor Absorption →

Related reference
  • Vitamin B12 · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Trump Administration Removes Job Protections for Thousands of Federal Health Workers

Thousands of federal health workers at HHS agencies including CDC, FDA, and…

Rare Lymphatic-Urinary Fistula Causes Milky Urine in NEJM Case Report

A rare case of chyluria caused by a lymphatic-urinary fistula demonstrates how…

Gene Therapy Shows Promise for Inherited Cholesterol Disorder in First-in-Human Trial

First-in-human gene therapy trial shows preliminary safety and efficacy for treating homozygous…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical chart showing STI prevalence rates among HIV-positive patients in China

Three Critical Takeaways From China’s Definitive HIV-STI Study for Clinical Practice

By
Prof. Giorgi Pkhakadze
24/06/2026
Medical illustration showing targeted cancer therapy mechanism

Three Key Insights from the Savolitinib Gastric Cancer Trial: What Clinicians Should Know

By
Prof. Giorgi Pkhakadze
02/07/2026
Clinical UpdatesNew StudiesPracticeResearch Digest

Phase 1 trials reveal safety profile of rimteravimab antibody for COVID-19 treatment

By
Prof. Giorgi Pkhakadze
03/06/2026
Healthcare worker examining infant in African clinic setting

Data Disparity: Severely Ill Infants Receive Care Half as Often as Mildly Sick Peers

By
Prof. Giorgi Pkhakadze
07/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up